WILLIAM C. FREDERICKS holds a B.A. (with high honors) from Swarthmore College (Pa.), an M. Litt. in International Relations from Oxford University (England), and a J.D. from Columbia University Law School (N.Y.).[nbsp] At Columbia, Mr. Fredericks was also a three-time Harlan Fiske Stone Scholar, a Columbia University International Fellow, and the winner of the law school’s Beck Prize (property law), Toppan Prize (advanced constitutional law), Greenbaum Prize (written advocacy), and Dewey Prize (oral advocacy).
After clerking for the Hon. Robert S. Gawthrop III (E.D. Pa.), Mr. Fredericks spent seven years practicing securities and complex commercial litigation at Simpson Thacher [&] Bartlett LLP and Willkie Farr [&] Gallagher LLP in New York before moving to the plaintiffs’ side of the bar in 1996.[nbsp] Since 1996, Mr. Fredericks has represented investors as a lead or co-lead plaintiff in dozens of securities class actions, including In re Wachovia Preferred Securities and Bond/Notes Litig., (S.D.N.Y.) (total settlements of $627 million, reflecting the largest recovery ever in a pure Securities Act case not involving any parallel government fraud claims); In re Rite Aid Securities Litig. (E.D. Pa.) (total settlements of $323 million, including the then-second largest securities fraud settlement ever against a Big Four accounting firm); In re Sears Roebuck [&] Co. Sec. Litig. (N.D. Ill.) ($215 million settlement, representing the largest §10(b) class action recovery ever not involving either a financial restatement or parallel government fraud claims); In re State Street ERISA Litig. (S.D.N.Y.) (one of the largest ERISA class settlements to date) and Irvine v. Imclone Systems, Inc. (S.D.N.Y.) ($75 million settlement).[nbsp] Mr. Fredericks also played a lead role on the team that obtained a rare 9-0 decision for securities fraud plaintiffs in the U.S. Supreme Court in Merck [&] Co., Inc. v. Reynolds, and has coauthored several amicus briefs in other Supreme Court cases involving securities issues (including the recent Halliburton and Amgen cases).
Mr. Fredericks is currently recognized in the 2012-13 edition of “America’s Best Lawyers” in the field of commercial litigation, and is a frequent panelist on securities litigation programs sponsored by various organizations, including the Practising Law Institute (PLI) and the American Law Institute/American Bar Association (ALI/ABA).[nbsp] He is also a member of the New York City Bar Association (former chair, Committee on Military Affairs and Justice), the Federal Bar Council and the American Bar Association.